AIM IMMUNOTECH INC. Increase (Decrease) in Accounts and Other Receivables
AIM IMMUNOTECH INC. (AIM) reported Increase (Decrease) in Accounts and Other Receivables of -$794.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2020-11-12
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for the quarter ending 2020-09-30 was -$20.00K.
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for the quarter ending 2020-06-30 was -$776.00K.
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for the quarter ending 2020-03-31 was $2.00K.
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for the quarter ending 2019-12-31 was $758.00K, a 28.89% decline year-over-year.
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for fiscal 2019 was -$274.00K, a 125.61% decline from fiscal 2018.
- AIM IMMUNOTECH INC. increase (decrease) in accounts and other receivables for fiscal 2018 was $1.07M.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 3 month as first filed | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$796.00K derived: sum of 2 quarters · filed 2020-11-12 | -$794.00K 10-Q · filed 2020-11-12 | -$36.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-06-30 | -$776.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$774.00K 10-Q · filed 2020-08-14 | -$16.00K derived: sum of 3 quarters · filed 2020-08-14 | -$30.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2020-03-31 | $2.00K 10-Q · filed 2020-05-14 | $760.00K derived: sum of 2 quarters · filed 2020-05-14 | $746.00K derived: sum of 3 quarters · filed 2020-11-12 | $721.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-12-31 | $758.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $744.00K derived: sum of 2 quarters · filed 2020-11-12 | $719.00K derived: sum of 3 quarters · filed 2020-11-12 | -$274.00K 10-K · filed 2020-03-30 | |
| 2019-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$39.00K derived: sum of 2 quarters · filed 2020-11-12 | -$1.03M 10-Q · filed 2020-11-12 | $34.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$1.02M 10-Q · filed 2020-08-14 | $48.00K derived: sum of 3 quarters · filed 2020-08-14 | $41.00K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$993.00K 10-Q · filed 2020-05-14 | $993.00K 10-Q · filed 2019-05-15 | $73.00K derived: sum of 2 quarters · filed 2020-05-14 | $66.00K derived: sum of 3 quarters · filed 2020-05-14 | $83.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.06M derived: sum of 2 quarters · filed 2020-03-30 | $1.08M derived: sum of 3 quarters · filed 2020-03-30 | $1.07M 10-K · filed 2020-03-30 | |
| 2018-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $10.00K derived: sum of 2 quarters · filed 2019-11-14 | $4.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $11.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | -$6.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |